Tonix Pharmaceuticals Holding Corp. (TNXP)
13.14
-0.23
(-1.72%)
USD |
NASDAQ |
Sep 04, 16:00
13.33
+0.19
(+1.45%)
After-Hours: 20:00
Tonix Pharmaceuticals Cash and Short Term Investments (Annual) : 207.64M for Dec. 31, 2025
Cash and Short Term Investments (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 207.64M |
| December 31, 2024 | 98.78M |
| December 31, 2023 | 24.95M |
| December 31, 2022 | 120.23M |
| December 31, 2021 | 178.66M |
| December 31, 2020 | 77.07M |
| December 31, 2019 | 11.25M |
| December 31, 2018 | 25.03M |
| December 31, 2017 | 25.50M |
| December 31, 2016 | 26.12M |
| Date | Value |
|---|---|
| December 31, 2015 | 43.02M |
| December 31, 2014 | 38.18M |
| December 31, 2013 | 8.202M |
| December 31, 2012 | 1.785M |
| December 31, 2011 | 0.0411M |
| December 31, 2010 | 0.0654M |
| December 31, 2009 | 0.0126M |
| December 31, 2008 | 0.0405M |
| December 31, 2007 | 0.014M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Annual) Benchmarks
| Exelixis, Inc. | 1.059B |
| Inovio Pharmaceuticals, Inc. | 58.51M |
| Heron Therapeutics, Inc. | 46.63M |
| ACADIA Pharmaceuticals, Inc. | 819.69M |
| Alnylam Pharmaceuticals, Inc. | 2.908B |